Safety perspectives on presently considered drugs for the
treatment of COVID-19.
Sophie L. Penmana*, Robyn T. Kiya*,
Rebecca L. Jensena*, Christopher
Beoku-Bettsb, Ana Alfirevica, David
Backa, Saye H. Khooa, Andrew
Owena, Munir Pirmohameda, B. Kevin
Parka, Xiaoli Menga#, Christopher
E. Goldringa#, Amy E. Chadwicka#
a MRC Centre for Drug Safety Science, Department of
Pharmacology and Therapeutics, University of Liverpool, Liverpool, L69
3GE, UK
b School of Medicine, University of Liverpool, L69
3GE, UK